Skip to Main Content

Paper Details

Into the future: A pilot study combining imaging with molecular profiling to predict resectability in ovarian cancer.
Gynecol Oncol
2
2022
HGSOC, MES, MES subtype tumors, MES tumor, Women, chemo-nave tumors, mRNA, mesenchymal, non, non-MES subtype, ovarian cancer, patients, tumor, tumor mRNA, women
Author NameAffiliation
Bryan M McCauleyDivision of Clinical Trials and Biostatistics, Mayo Clinic
Stacey J WinhamMayo Clinic
Susan J RamusSchool of Clinical Medicine, University of NSW Sydney, Lowy Cancer Research Centre
Susan J RamusSchool of Clinical Medicine, University of NSW Sydney, Lowy Cancer Research Centre
Michael S AnglesioVancouver General Hospital, and University of British Columbia, University of British Columbia
Michael S AnglesioVancouver General Hospital, and University of British Columbia, University of British Columbia
Gary L Keeney
Ellen L GoodeMayo Clinic
  • 1 - 8

Datasets

Release 1.2